Understand Your Body.
Take Control of Your Health.
Gynexa is a women’s health companion designed to help you track symptoms, recognise patterns and prepare for appointments with more confidence.
Living with gynaecological conditions can feel overwhelming.
From endometriosis and adenomyosis to PCOS, fibroids and chronic pelvic pain, many women are left trying to remember symptoms, flare-ups, medication changes and appointment details on their own.
Everything in one calm, simple place.
Built to support women before, during and after appointments.
Daily Symptom Tracking
Log pain, bleeding, mood, fatigue, bowel symptoms, sleep and more in under 30 seconds.
Health Insights
Spot patterns in your symptoms over time so you can better understand your body.
Medication Tracker
Keep track of treatments, reminders, side effects and whether medication is helping.
Doctor Reports
Generate clear summaries to help you prepare for medical appointments.
Cycle Tracking
Understand how symptoms change throughout your cycle and around flare-ups.
Private & Secure
Your health data belongs to you. Privacy and trust are central to Gynexa.
Conditions we support
Gynexa is being designed for women living with chronic gynaecological and pelvic health conditions.
How Gynexa works
Simple tools to help you feel more prepared and in control.
Track
Complete quick daily check-ins about symptoms, medication, mood and cycle changes.
Understand
See patterns and trends that may help you understand what affects your symptoms.
Prepare
Use clear reports to support conversations with doctors and specialists.
Be among the first to experience Gynexa.
Join the waitlist for early access, product updates and the chance to help shape the future of women’s health.
FAQ
Is Gynexa free?
Gynexa will offer a free version with optional premium features in the future.
Can Gynexa diagnose medical conditions?
No. Gynexa helps you track and understand your health. It does not provide medical diagnoses or replace professional medical advice.
When will the app launch?
Gynexa is currently in early development. Join the waitlist to receive updates and early access opportunities.